Advertisement
Home Tags Drug Safety

Tag: Drug Safety

Overdose Deaths Involving Counterfeit Pills Increasing in U.S.

0

Quarterly percentage of deaths more than doubled with evidence of counterfeit pill use from July to September 2019 to October to December 2021

Recent Increase Seen in Pediatric Benzonatate Exposure

0

77 percent of the cases of pediatric exposure reported to U.S. poison control centers were for unintentional exposure

Most Safety Signals Reported to FDA Lead to Regulatory Action

0

Regulatory actions by the FDA were corroborated by at least one relevant published research study for 17 of 57 resolved safety signals

Many Psychiatric Patients Are Getting Risky Drug Gabapentin ‘Off-Label’

0
By Amy Norton HealthDay Reporter MONDAY, Nov. 22, 2021 (HealthDay News) -- Most prescriptions for the medication gabapentin are for unapproved uses -- and many...
The pooled prevalence of preventable patient harm is 6 percent across a range of medical settings globally

About One in 20 Patients Exposed to Preventable Harm

0
Pooled prevalence of preventable patient harm was 6 percent; 12 percent was severe, led to death
Use of pantoprazole for up to three years to prevent upper gastrointestinal events in patients receiving anticoagulant therapy with aspirin and/or rivaroxaban has a similar safety profile to placebo except for an increased risk for enteric infections

PPI Use for Up to Three Years Safe During Anticoagulant Tx

0
Safety profile did not differ for pantoprazole versus placebo except greater risk for enteric infections
A safety statement was issued yesterday by the U.S. Food and Drug Administration regarding risks found to be associated with the investigational use of Venclexta (venetoclax) for treatment of patients with multiple myeloma.

FDA: Higher Risk for Death Found With Venclexta in Multiple Myeloma

0
Enrollment suspended for trials investigating Venclexta for treatment of multiple myeloma
A bipartisan bill meant to combat the United States' opioid abuse epidemic was signed into law Oct. 24 by President Donald Trump.

Bill to Fight U.S. Opioid Crisis Signed Into Law

0
Legislation expands treatment options, removes ban on Medicaid reimbursement at certain facilities
The percentage of U.S. men receiving testosterone prescriptions decreased from 2013 through 2016

Testosterone Prescribing Down Since 2013

0
Decline coincided with reports linking testosterone to adverse cardiovascular events
Nine new drug labeling and packaging guidelines have been developed with an aim of reducing medication errors

International Group Develops Best Practices for Drug Packaging

0
Global regulators recommend adoption of ready-to-use/administer syringes and premixed IV solutions